Treatment phase duration by age group
| . | Induction . | Consolidation . | Reinduction . | Intensification . | Maintenance 1B . | Maintenance 1A . |
|---|---|---|---|---|---|---|
| Planned duration | 6 | 6 | 8 | 6 | 42 | 42 |
| Congenital ALL | ||||||
| Patients with available data | 19 | 14 | 11 | 4 | 4 | 2 |
| Actual duration (median) | 7.0 | 8.1 | 9.6 | 8.8 | 42.7 | 44.4 |
| Infant ALL (1-12 mo) | ||||||
| Patients with available data | 335 | 288 | 209 | 69 | 98 | 14 |
| Actual duration (median) | 6.3 | 7.8 | 10.1 | 8.7 | 41.9 | 43.1 |
| P* | 0.22 | 0.50 | 0.26 | 0.84 | 0.55 |
| . | Induction . | Consolidation . | Reinduction . | Intensification . | Maintenance 1B . | Maintenance 1A . |
|---|---|---|---|---|---|---|
| Planned duration | 6 | 6 | 8 | 6 | 42 | 42 |
| Congenital ALL | ||||||
| Patients with available data | 19 | 14 | 11 | 4 | 4 | 2 |
| Actual duration (median) | 7.0 | 8.1 | 9.6 | 8.8 | 42.7 | 44.4 |
| Infant ALL (1-12 mo) | ||||||
| Patients with available data | 335 | 288 | 209 | 69 | 98 | 14 |
| Actual duration (median) | 6.3 | 7.8 | 10.1 | 8.7 | 41.9 | 43.1 |
| P* | 0.22 | 0.50 | 0.26 | 0.84 | 0.55 |
Patients in numbers. Durations in weeks.
Comparison of phase duration in congenital ALL patients versus ALL patients aged 1-12 months.